Feature Articles

Reflections on the Bayeux Tapestry

Editorial by Bruce Shriver

AP23573: A Review of Recent Results

Drs. Chawla, Sankhala, Mita, and Tolcher discuss AP23573, an mTOR inhibitor, which was granted fast-track designation by the FDA for patients with soft tissue and bone sarcomas. It is a unique and promising agent for treating sarcoma.

Clear Cell Sarcoma and Alveolar Soft Part Sarcoma

Drs. Goldberg and Albritton discuss two very rare soft tissue sarcomas, clear cell sarcoma and alveolar soft part sarcoma. They explore why some investigators propose that they may have a molecular similarity that could serve as a target for treatment using a vaccine.

Have We Made Any Progress?

Dr. Murray F. Brennan, who recently received the Nobility in Science award from the Sarcoma Foundation of America, shares with us some of his insights about the progress that has been made in dealing with sarcoma over the last 30-years.

An Update on the Amschwand Sarcoma Cancer Foundation

Ginger Kyle discusses some of the current and future programs of the Amschwand Sarcoma Cancer Foundation.

Update on the Northwest Sarcoma Foundation

Karen Murphy discusses some of the current and future programs of the Northwest Sarcoma Foundation.

The State of the Sarcoma Alliance 2005

Arthur Beckert discusses some of the current and future programs of the Sarcoma Alliance.

Regular Columns

Stories of Courage and Hope

Abstracts of inspiring stories we have recently encountered about sarcoma patients, survivors, caregivers and those who have lost a loved one to sarcoma.

Our Initiatives

Advance Announcement: Team Sarcoma 2006 Danish Bike Tour: July 1-7, 2006 in Denmark.

The Electronic Sarcoma Update Newsletter is an online peer-reviewed newsletter that contains articles of interest to patients, caregivers, physicians, and nurses. ESUN is published bi-monthly and has regular columns discussing:

Specific sarcomas
Current issues in sarcoma treatment
Participatory medicine
Recent research findings
Answers to readers' questions
Stories of courage and hope

ESUN has an outstanding Medical Editorial Board and is a vital source of information for thousands of readers worldwide.

Free Subscriptions

To be notified by e-mail when a new issue of ESUN has been published, please send us a message that includes your name and e-mail address.

Topics and Feedback

Please send us your recommendations for topics to be covered in ESUN, as well as any other comments or feedback that can be useful to us.

Information for Authors

We welcome contributions of essays and articles that are relevant to ESUN and its intended audience.
If you would like to write an article for ESUN, please contact us and we will send you our Guidelines for Authors.

Contact Information

ESUN
17 Bethea Drive
Ossining, New York 10562-1620
Phone: (914) 762-3251
Fax: (914) 941-9181
E-mail: esun@sarcomahelp.org

Disclaimer

Information on the The Initiative's website and in the Electronic Sarcoma Update Newsletter (ESUN) is provided on an "as is" basis for general information only. It is not intended as medical advice and should not be relied upon as a substitute for consultations with qualified health professionals who are familiar with your individual medical needs. We caution readers and internet users to take care when using "medical advice" obtained on the web or in newsletters such as this. If you are concerned about your medical condition or that of a family member, loved one, or friend, we strongly recommend that you consult a physician. Although we carefully review our content, The Initiative cannot guarantee nor take responsibility for the medical accuracy of documents we publish, nor can it assume any liability for the content of the various websites that we link to or that are linked to The Initiative's website. We believe the information on our website and in ESUN provides you with a starting point for a discussion with your physician who can give you his/her opinion about it.

Copyright

Articles from the Electronic Sarcoma Update Newsletter are peer-reviewed, professional content that is fully copyrighted. You cannot publish or redistribute these articles for commercial purposes without written permission from us. You can publish or redistribute these articles for non-commercial purposes without written permission, as long as the content is attributed to the Liddy Shriver Sarcoma Initiative. For more information, see the complete Terms of Use of this website.

Medical Editorial and Advisory Board

Karen Albritton, MD, Dana-Farber Cancer Institute
Laurence Baker, DO, Southwest Oncology Group and SARC
Jean-Yves Blay, MD, PhD, Université Claude Bernard in Lyon, France
Murray Brennan, MD, Memorial Sloan-Kettering Cancer Center
Mark Gebhardt, MD, Harvard University, Beth Israel Deaconess Medical Center
Richard Gorlick, MD, The Children's Hospital at Montefiore
Mary Louise Keohan, MD, Memorial Sloan-Kettering Cancer Center
Crystal Mackall, MD, National Cancer Institute
Ole Steen Nielsen, MD, University of Aarhus in Aarhus, Denmark
Raphael Pollock, MD, PhD, University of Texas M. D. Anderson Cancer Center
R. Lor Randall, MD, University of Utah, Huntsman Cancer Institute
Luca Sangiorgi, MD, PhD, Rizzoli Orthopaedic Institute (IOR), Italy
Leonard Wexler, MD, Memorial Sloan-Kettering Cancer Center